Benchmark Research | Austin, TX

Research site
2900 Sunridge Drive,1, Austin, Texas, United States of America

Site insights

Top conditions

Top treatments


Parent organization

This site is a part of Benchmark Research

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 10 total trials

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immun...

Active, not recruiting
Biological: mRNA-1083.3
Biological: Influenza Vaccine 1

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vaccine is compared to...

Active, not recruiting
Biological: COVID-19 Vaccine
Biological: Investigational influenza vaccine

This study is a large-scale investigation (Phase 3) into a new booster shot designed specifically for teenagers. The booster targets a particular var...

Active, not recruiting
Biological: Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
Biological: NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine

This study is to understand if the study vaccine (called VLA15) is safe in healthy children.We are looking for children who:* are healthy* are age 5...

Active, not recruiting
Lyme Disease
Biological: VLA15
Other: Normal Saline

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Lower Respiratory Tract Illness
Biological: Placebo
Biological: RSVpreF

An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody response of a vaccine to prevent s...

Clostridoides Difficile Associated Disease
Biological: C. difficile vaccine (previously studied formulation).
Biological: C. difficile vaccine formulation 1.

Trial sponsors

Pfizer logo
Moderna logo
Novavax logo
BioNTech logo
Ocuphire Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems